USPTO serial 88221562
MONOTX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 25, 2020
- Examiner
- MEYERS, MORGAN LAURA
- Law office
- Historical data usage
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with MONOTX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*
Plus Government fees of $1,275
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Mononuclear Therapeutics Limited
Shatin NT, HK
Mononuclear Therapeutics Limited
Shatin NT, HK
Mononuclear Therapeutics Limited
Shatin NT, HK
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Charles J. Meyer
Charles J. Meyer Woodard, Emhardt, Henry, Reeves & Wagner, LLP111 Monument Circle, Suite 3700Indianapolis, IN 46204-5137United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 039 | Storage and retrieval of blood, tissue and stem cells for medical research, treatment and diagnostics; storage and retrieval of blood and blood components for medical research; biomedical services namely, the storage of human cells, specifically umbilical cord blood, umbilical cord blood cells, and stem cells for medical use and research use | ACTIVE | Nov 1, 2019 |
| 042 | Research and development services in cellular therapy, in particularly, research and development in the field of treatment and medical diagnosis using cellular, molecular, biotechnological and genetic methods, and in the field of development of monuclear cell therapy; research and development of individualized medicine, development of treatment plan and therapy adapted for individual patients; biomedical laboratory services for others, namely, the collection, extraction, processing, cryopreservation, analysis, screening, testing, typing and storage of umbilical cord blood, placenta, human tissues and stem cells; genetic testing services for research purposes; consultation, research and development relating to scientific research; research and development relating to medicine and healthcare products; development of testing methods in the fields of cellular therapy | ACTIVE | Nov 1, 2019 |
| 044 | Collection and testing of cord blood, blood components, tissue and stem cells for medical research; medical diagnostic testing relating to cord blood, placenta tissue, human body | ACTIVE | Nov 1, 2019 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Mononuclear Therapeutics Limited
- Other trademarks owned by Mononuclear Therapeutics Limited
- Other trademarks owned by Mononuclear Therapeutics Limited
- Other trademarks in Class 039
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named MONOTX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 14, 2026 | NAS8 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | — |
| Sep 14, 2026 | 8.OK | REGISTERED - SEC. 8 (6-YR) ACCEPTED | The USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline. |
| Sep 7, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jul 6, 2026 | ES8R | TEAS SECTION 8 RECEIVED | — |
| Aug 25, 2025 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Dec 22, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 22, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 22, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 25, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 23, 2020 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Jul 22, 2020 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Jun 30, 2020 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Jun 30, 2020 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jun 10, 2020 | IUAF | USE AMENDMENT FILED | — |
| Jun 10, 2020 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jan 29, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 29, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 10, 2019 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 15, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 15, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 25, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 25, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 25, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 12, 2019 | ALIE | ASSIGNED TO LIE | — |
| Sep 10, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 9, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 8, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 8, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 13, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 13, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 13, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 6, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 31, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 11, 2018 | NWAP | NEW APPLICATION ENTERED | — |